IL169687A0 - Methods for the drug prophylaxis of poisoning by cholinesterase inhibitors, and active ingredients and medicaments suitable therefore - Google Patents

Methods for the drug prophylaxis of poisoning by cholinesterase inhibitors, and active ingredients and medicaments suitable therefore

Info

Publication number
IL169687A0
IL169687A0 IL169687A IL16968705A IL169687A0 IL 169687 A0 IL169687 A0 IL 169687A0 IL 169687 A IL169687 A IL 169687A IL 16968705 A IL16968705 A IL 16968705A IL 169687 A0 IL169687 A0 IL 169687A0
Authority
IL
Israel
Prior art keywords
poisoning
methods
active ingredients
cholinesterase inhibitors
medicaments suitable
Prior art date
Application number
IL169687A
Other languages
English (en)
Original Assignee
Lohmann Therapie Syst Lts
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lohmann Therapie Syst Lts filed Critical Lohmann Therapie Syst Lts
Publication of IL169687A0 publication Critical patent/IL169687A0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/325—Carbamic acids; Thiocarbamic acids; Anhydrides or salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
IL169687A 2003-01-17 2005-07-14 Methods for the drug prophylaxis of poisoning by cholinesterase inhibitors, and active ingredients and medicaments suitable therefore IL169687A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10301851A DE10301851A1 (de) 2003-01-17 2003-01-17 Verfahren zur medikamentösen Prophylaxe gegen Vergiftungen durch Cholinesterase-Hemmer, sowie hierfür geeignete Wirkstoffe und Arzneimittel
PCT/EP2004/000289 WO2004064829A1 (de) 2003-01-17 2004-01-16 Verfahren zur medikamentösen prophylaxe gegen vergiftungen durch cholinesterase-hemmer, sowie hierfür geeignete wirkstoffe und arzneimittel

Publications (1)

Publication Number Publication Date
IL169687A0 true IL169687A0 (en) 2007-07-04

Family

ID=32602728

Family Applications (1)

Application Number Title Priority Date Filing Date
IL169687A IL169687A0 (en) 2003-01-17 2005-07-14 Methods for the drug prophylaxis of poisoning by cholinesterase inhibitors, and active ingredients and medicaments suitable therefore

Country Status (9)

Country Link
US (1) US20060183796A1 (https=)
EP (1) EP1585514A1 (https=)
JP (1) JP2006516267A (https=)
KR (1) KR20050104347A (https=)
CN (1) CN1741800A (https=)
BR (1) BRPI0406580A (https=)
DE (1) DE10301851A1 (https=)
IL (1) IL169687A0 (https=)
WO (1) WO2004064829A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2936150B1 (fr) * 2008-09-19 2013-09-06 Dermathologiques D Uriage Lab Nouvelles compositions dermatologiques protectrices de la peau et des muqueuses
GB0809905D0 (en) * 2008-06-02 2008-07-09 Secr Defence A Transdermal drug delivery device
CN115989025A (zh) * 2020-08-31 2023-04-18 耐贝医药株式会社 用于缓解或治疗神经退行性疾病的症状的贴剂

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL74497A (en) * 1985-03-05 1990-02-09 Proterra Ag Pharmaceutical compositions containing phenyl carbamate derivatives and certain phenyl carbamate derivatives
ES2201050T3 (es) * 1991-09-26 2004-03-16 The Government Of The Usa As Represented By The Secretary Of Department Of Health And Human Services Compuestos que presentan una inhibicion selectiva de la acteil-colinesterasa.
DE4342174C1 (de) * 1993-12-10 1995-05-11 Lohmann Therapie Syst Lts Transdermales therapeutisches System sowie ein Verfahren zur Herstellung eines transdermalen therapeutischen Systems zur kombinierten transdermalen Anwendung von Physostigmin und Scopolamin für die Prophylaxe und zur Vorbehandlung einer Vergiftung durch hochtoxische phosphororganische Nervengifte, insbesondere Soman und seine Verwendung
DE4342173A1 (de) * 1993-12-10 1995-06-14 Lohmann Therapie Syst Lts Pharmazeutische Formulierung zur Prophylaxe bzw. Vorbehandlung einer Vergiftung durch phosphororganische Cholinesterasehemmer
US5807671A (en) * 1995-01-09 1998-09-15 Yissum Research Development Company Of Hebrew University Of Jerusalem Method of screening for genetic predisposition to anticholinesterase therapy
US6955819B2 (en) * 1998-09-29 2005-10-18 Zars, Inc. Methods and apparatus for using controlled heat to regulate transdermal and controlled release delivery of fentanyl, other analgesics, and other medical substances
JP4422342B2 (ja) * 1998-11-27 2010-02-24 ザノヒェミア・ファルマツォイティカ・アー・ゲー せん妄の治療へのコリン作動性中枢神経系エフェクターの使用
US6756385B2 (en) * 2000-07-31 2004-06-29 Pfizer Inc. Imidazole derivatives

Also Published As

Publication number Publication date
WO2004064829A1 (de) 2004-08-05
DE10301851A1 (de) 2004-07-29
BRPI0406580A (pt) 2005-12-20
JP2006516267A (ja) 2006-06-29
CN1741800A (zh) 2006-03-01
US20060183796A1 (en) 2006-08-17
KR20050104347A (ko) 2005-11-02
EP1585514A1 (de) 2005-10-19

Similar Documents

Publication Publication Date Title
AU2003244632A1 (en) Bicyclo-pyrazoles active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
AU2003244649A1 (en) Bicyclo-pyrazoles active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
ZA200705750B (en) Compositions and methods for stabilizing active pharmaceutical ingredients
EA200501586A1 (ru) Фармацевтические продукты
ZA200301813B (en) Bicyclo-pyrazoles active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them.
AU2003227741A1 (en) Aminoindazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
IL163831A0 (en) Derivatives of aminoindazoles, method of preparation and intermediates of the method as drugs pharmaceutical compounds containing
WO2005041925A3 (en) Compositions and dosage forms for enhanced absorption
AU2003222786A1 (en) Chemical compounds with dual activity, processes for their preparation and pharmaceutical compositions
WO2003082247A3 (en) Drug microparticles
EP1790637A4 (en) NITROGENIC HETEROCYCLIC DERIVATIVE AND THIS MEDICAMENT CONTAINING ACTIVE SUBSTANCE
IL183753A0 (en) Multiparticulate form of administration, comprising nucleic acid-containing mucoadhesive active ingredients, and method for producing said form of administration
IL229510A0 (en) A dosage form containing pantoprazole as an active ingredient
IL162765A (en) Diazabicycle derivatives, processes for their preparation, pharmaceutical compositions comprising them and their medical use
EP1536811A4 (en) METHOD OF EXTRACTING AND PURIFYING THE ACTIVE INGREDIENTS OF THE I LONICERA JAPONICA / I ROD, AND THEIR USE IN ANTI-INFLAMMATORY AND ANALGESIC DRUGS
ZA200506422B (en) Substituted 4-phenyltetrahydroisoquinolines, method for the production thereof, the use of the same as medicaments, and medicament containing such compounds
AU2002358676A1 (en) Hydroxyphenyl-pyrazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
EP1589950A4 (en) PROCESS FOR PREPARING PHARMACEUTICAL PHARMACEUTICAL FORMS COMPRISING ACTIVE COMPRESSION COMPONENTS
AU2003246567A1 (en) Administration form for the oral administration of active substances, vitamins, and/or nutrients
IL163643A0 (en) Oxazolidinone derivatives, processes for their forpreparation, and pharmaceutical compositions containing them
EP1731609A4 (en) INHIBITOR OF THE EXPRESSION OF RAD51, MEDICAMENT CONTAINING THE INHIBITOR AS ACTIVE INGREDIENT AND USE THEREOF
WO2004098577A3 (en) Dosage form containing (s)-pantoprazole as active ingredient
AU2003246566A1 (en) Administration form for the oral administration of active substances, vitamins, and/or nutrients
IL169687A0 (en) Methods for the drug prophylaxis of poisoning by cholinesterase inhibitors, and active ingredients and medicaments suitable therefore
AU2002325614A1 (en) Compounds containing lactic acid elements, method for the production and use thereof as pharmaceutically active substances